{"id":467,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","title":{"rendered":"MK-677 \/ Ibutamoren: estado cl\u00ednico, se\u00f1al de insuficiencia card\u00edaca y cuestiones materiales"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">MK-677, MK-0677 e ibutamoren son nombres que se encuentran en la misma historia de desarrollo. La existencia de ensayos en humanos no significa que el compuesto sea un f\u00e1rmaco aprobado, ni borra los ensayos que no lograron mostrar beneficios funcionales o plantearon preocupaciones de seguridad.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Lo que muestra el registro<\/h2><ul class=\"wp-block-list\"><li>Ibutamoren no es un ingrediente activo aprobado por FDA.<\/li><li>Un ensayo de fractura de cadera en un paciente de 123 se detuvo poco despu\u00e9s de una se\u00f1al de insuficiencia card\u00edaca congestiva.<\/li><li>La identidad y el ensayo deben distinguir la forma libre de ibutamor\u00e9n del mesilato de ibutamor\u00e9n.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png\" alt=\"Cient\u00edfico revisando datos de investigaci\u00f3n sobre la hormona de crecimiento puls\u00e1til y IGF-1\" class=\"wp-image-459\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Ilustraci\u00f3n editorial original utilizada para identificar el tema de la investigaci\u00f3n. No representa un lote de cat\u00e1logo, medicamento aprobado, resultado de ensayo o uso cl\u00ednico.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">La frontera entre identidad y evidencia<\/h2><p class=\"wp-block-paragraph\">Un certificado debe indicar la forma molecular exacta, no utilizar el nombre original y el mesilato indistintamente. La masa molecular, el c\u00e1lculo del ensayo y el contenido por contenedor dependen de esa elecci\u00f3n.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Sin\u00f3nimos en la literatura<\/strong><span>MK-677, MK-0677, ibutamoren<\/span><\/div><div class=\"pim-evidence-row\"><strong>Problema de sal\/forma<\/strong><span>Ibutamoren vs mesilato de ibutamoren<\/span><\/div><div class=\"pim-evidence-row\"><strong>Contexto de seguridad<\/strong><span>Efectos de la glucosa\/insulina, edema y se\u00f1al CHF<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Qu\u00e9 pertenece al registro de materiales<\/h2><p class=\"wp-block-paragraph\">Los res\u00famenes de marketing frecuentemente seleccionan el aumento de IGF-1 o masa libre de grasa y omiten los resultados funcionales negativos. Una p\u00e1gina defendible mantiene intacta la jerarqu\u00eda de resultados y cita el ensayo detenido sobre fractura de cadera, as\u00ed como el estudio m\u00e1s prolongado con adultos mayores sanos.<\/p><h2 class=\"wp-block-heading\">Regla editorial<\/h2><p class=\"wp-block-paragraph\">Utilice el nombre exacto de la intervenci\u00f3n, el modelo, la poblaci\u00f3n y el criterio de valoraci\u00f3n del registro citado. No convierta una asociaci\u00f3n, mecanismo, resultado en animales, registro de medicamento terminado aprobado o prueba anal\u00edtica en una afirmaci\u00f3n sobre un lote de cat\u00e1logo no relacionado.<\/p>","protected":false},"excerpt":{"rendered":"<p>MK-677, MK-0677 e ibutamoren son nombres que se encuentran en la misma historia de desarrollo. La existencia de ensayos en humanos no significa que el compuesto sea un f\u00e1rmaco aprobado, ni borra los ensayos que no lograron mostrar beneficios funcionales o plantearon preocupaciones de seguridad.<\/p>","protected":false},"author":1,"featured_media":632,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"351","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Randomized trials and FDA compounding review","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"MK-677 in healthy older adults: two-year randomized trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18981485\/\",\"note\":\"Body composition, function and glucose findings; PMID 18981485.\"},{\"title\":\"MK-0677 phase IIb hip-fracture study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21067829\/\",\"note\":\"Early termination after CHF signal; PMID 21067829.\"},{\"title\":\"FDA Pharmacy Compounding Advisory Committee meeting materials\",\"url\":\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/october-29-2024-meeting-pharmacy-compounding-advisory-committee-10292024\",\"note\":\"FDA assessment materials for ibutamoren and ipamorelin.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MK-677 Clinical Status, Safety Signals &amp; Quality Questions<\/title>\n<meta name=\"description\" content=\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\" \/>\n<meta property=\"og:description\" content=\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"MK-677 \\\/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"},\"wordCount\":242,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\",\"name\":\"MK-677 Clinical Status, Safety Signals & Quality Questions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MK-677 \\\/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MK-677 Estado cl\u00ednico, se\u00f1ales de seguridad y preguntas de calidad","description":"MK-677, MK-0677 e ibutamoren son nombres que se encuentran en la misma historia de desarrollo. La existencia de ensayos en humanos no significa que el compuesto est\u00e9 aprobado...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","og_locale":"es_ES","og_type":"article","og_title":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions","og_description":"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026","og_url":"https:\/\/nhdbio.com\/es\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"wordCount":242,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","url":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","name":"MK-677 Estado cl\u00ednico, se\u00f1ales de seguridad y preguntas de calidad","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"MK-677, MK-0677 e ibutamoren son nombres que se encuentran en la misma historia de desarrollo. La existencia de ensayos en humanos no significa que el compuesto est\u00e9 aprobado...","breadcrumb":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=467"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/467\/revisions"}],"predecessor-version":[{"id":509,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/467\/revisions\/509"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/632"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}